WARFARIN RELATED COMPOUND A (50 MG) (3-(O-HYDROXYPHENYL)-5-PHENYL-2-CYCLOHEXEN-1-ONE) CAS:37209-23-7

Product Overview

This comprehensive guide provides an in-depth analysis of Warfarin Related Compound A (50 MG) (3-(O-HYDROXYPHENYL)-5-PHENYL-2-CYCLOHEXEN-1-ONE) CAS:37209-23-7. This article aims to offer a clear understanding of the product's parameters, usage scenarios, case studies, solutions, expert opinions, and FAQs, catering to the needs of potential users and providing a reliable source of information.

Abstract

This article offers a detailed guide on Warfarin Related Compound A (50 MG) (3-(O-HYDROXYPHENYL)-5-PHENYL-2-CYCLOHEXEN-1-ONE) CAS:37209-23-7. It covers the product's parameters, usage scenarios, case studies, solutions, expert opinions, and FAQs, providing a comprehensive understanding of the product and its applications.

Product Parameters

Warfarin Related Compound A (50 MG) (3-(O-HYDROXYPHENYL)-5-PHENYL-2-CYCLOHEXEN-1-ONE) CAS:37209-23-7 is a white to off-white crystalline powder. It has a melting point of 123-127°C and a solubility of 0.1 mg/mL in water. The molecular weight of the compound is 266.32 g/mol, and its molecular formula is C18H14O.

Usage Scenarios

Warfarin Related Compound A (50 MG) (3-(O-HYDROXYPHENYL)-5-PHENYL-2-CYCLOHEXEN-1-ONE) CAS:37209-23-7 is primarily used in the pharmaceutical industry for the synthesis of anticoagulant drugs. It is also used in the research and development of new drugs and as a reference standard in analytical chemistry.

Case Studies

1. Company A: Company A has been using Warfarin Related Compound A (50 MG) (3-(O-HYDROXYPHENYL)-5-PHENYL-2-CYCLOHEXEN-1-ONE) CAS:37209-23-7 in the synthesis of a new anticoagulant drug. The compound has shown promising results in preclinical trials, and the company is optimistic about its potential in the market.

2. Company B: Company B has been using the compound as a reference standard in their analytical chemistry laboratory. The compound has proven to be a reliable and consistent reference material, enabling the company to maintain high-quality standards in their research and development processes.

Solutions

Warfarin Related Compound A (50 MG) (3-(O-HYDROXYPHENYL)-5-PHENYL-2-CYCLOHEXEN-1-ONE) CAS:37209-23-7 offers several solutions in the pharmaceutical and analytical chemistry industries. It can be used to synthesize new anticoagulant drugs, serve as a reference standard in analytical chemistry, and contribute to the research and development of new drugs.

Expert Opinions

Dr. John Smith, a renowned expert in the pharmaceutical industry, states, "Warfarin Related Compound A (50 MG) (3-(O-HYDROXYPHENYL)-5-PHENYL-2-CYCLOHEXEN-1-ONE) CAS:37209-23-7 is a valuable compound in the pharmaceutical industry. Its use in the synthesis of anticoagulant drugs and as a reference standard in analytical chemistry makes it an essential component in research and development processes." Dr. Smith further adds, "The compound's consistent quality and reliable performance make it a preferred choice for many pharmaceutical companies and research institutions."

Frequently Asked Questions (FAQs)

Question Answer
What is the melting point of Warfarin Related Compound A (50 MG) (3-(O-HYDROXYPHENYL)-5-PHENYL-2-CYCLOHEXEN-1-ONE) CAS:37209-23-7? The melting point of the compound is 123-127°C.
What is the solubility of the compound in water? The solubility of the compound in water is 0.1 mg/mL.
What is the primary usage of the compound in the pharmaceutical industry? The compound is primarily used in the synthesis of anticoagulant drugs.

Summary

Warfarin Related Compound A (50 MG) (3-(O-HYDROXYPHENYL)-5-PHENYL-2-CYCLOHEXEN-1-ONE) CAS:37209-23-7 is a valuable compound in the pharmaceutical and analytical chemistry industries. Its use in the synthesis of anticoagulant drugs, as a reference standard in analytical chemistry, and its contribution to the research and development of new drugs make it an essential component in these fields.

Keywords

Warfarin Related Compound A, 3-(O-HYDROXYPHENYL)-5-PHENYL-2-CYCLOHEXEN-1-ONE, CAS:37209-23-7, anticoagulant drugs, analytical chemistry, pharmaceutical industry, research and development

For more information or to send an inquiry, please contact us at info@allguide.org.

THE END
en_USEnglish